ArticleSmart molecules : open access2025
Enzyme-activatable dual-locked fluorescent probe for precision imaging of cutaneous squamous cell carcinoma.
Article in Smart molecules : open access, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Smart mesoporous silica nanoparticles for precision cancer therapy: Tumor targeting and stimuli-responsive controlled release.Smart molecules : open access · 2026Review
- Enzyme-Activatable Fluorogenic Probes: Design Strategies, Biomedical Applications, and Future Perspectives.Journal of the American Chemical Society · 2026Review
- Revisiting small-molecule fluorescent probes in food freshness detection.Smart molecules : open access · 2026Review
- A novel water-soluble near-infrared fluorescent probe for monitoring viscosity fluctuations in plants and zebrafish under abiotic stresses.Smart molecules : open access · 2026Article
- An ESIPT-AIE nanosensor for ONOOJournal of nanobiotechnology · 2026Article
- Advances in near-infrared fluorescent probes for the tumor microenvironment.Journal of translational medicine · 2026Review
- Self-assembled fluorescent nanosensor for ultrafast and field-deployable monitoring of herbicide fomesafen in multiple matrices.Journal of nanobiotechnology · 2026Article
- Enzyme-activatable dual-locked fluorescent probe for precision imaging of cutaneous squamous cell carcinoma.Smart molecules : open access · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous squamous cell carcinoma (cSCC), the second most common skin cancer, requires early and accurate detection to optimize clinical management. Fluorescence imaging has emerged as a non-invasive and cost-effective tool with high sensitivity for tumor diagnosis; however, existing probes for cSCC are limited in achieving rapid and specific imaging. In this study, we introduce
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.